
CYP2D6*4 polymorphism: A new marker of response to hormonotherapy in male breast cancer?
Keywords: بقاء بدون بیماری; Male breast cancer; Tamoxifen; CYP2D6*4 polymorphism; Disease-free survival; Overall-survival;